Search Within

Sandra Pierina D'Angelo

  1. "Sarcoma Surgeons"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (22)
Groups
  1. Department of Medicine (50)
  2. Hematologic Malignancies, Division of (50)
  3. Sarcoma Service (50)
  4. Sarcoma Surgeons (50)
  5. Solid Tumor Oncology Division (50)
  6. Surgery (50)

More Groups

People
  1. William Tap (47)
  2. Samuel Singer (45)
  3. Mark Dickson (40)
  4. Mary Keohan (40)
  5. Mrinal Gounder (40)
  6. Cristina Antonescu (37)

More People

Years
  1. 2024 (7)
  2. 2023 (6)
  3. 2022 (11)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Clinical Cancer Research (6)
  3. Annals of Oncology (5)
  4. American Journal of Surgical Pathology (3)
  5. Nature Communications (3)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. Oxford University Press (7)
  3. American Association for Cancer Research (6)
  4. Nature Publishing Group (4)
  5. Lippincott Williams & Wilkins (3)
  6. Springer (3)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • An open label phase IIa study evaluating the preliminary efficacy of intratumoural tigilanol tiglate (TT) in advanced and/or metastatic soft tissue sarcoma (STS)
    Meeting Abstract

    Bartlett, E. K.; Li, D.; Shemla, S.; Ariyan, C. E.; Dickinson, S.; Crago, A.; Li, G.; Agaram, N.; D'Angelo, S. P.; Maki, R. G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinicopathologic and molecular correlates to neoadjuvant chemotherapy-induced pathologic response in breast angiosarcoma
    Journal Article

    Chang, H. Y.; Dermawan, J. K.; Kuba, M. G.; Crago, A. M.; Singer, S.; Tap, W.; Chi, P.; D'Angelo, S.; Rosenbaum, E.; Antonescu, C. R.
    Genes Chromosomes and Cancer (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma
    Meeting Abstract

    Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save